Steady UDG gets a clean bill of health
I held my nerve when UDG Healthcare’s share price plummeted, and the recent annual report vindicated my faith, with plenty of cause for medium-term optimism
Until a few months ago, UDG Healthcare was the second-best performing asset in my equity portfolio. In February 2015, I bought the shares at £4.16. They hit a peak at £9.40 in May this year so, notwithstanding the drop in sterling since my purchase, I wasn’t complaining. With a sterling book profit of 125 per cent, the currency loss against the euro was easily absorbed.
However, the recent downward trend in the company’s ...
